Allison Beck
Overview
Explore the profile of Allison Beck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Happe M, Hofstetter A, Wang J, Yamshchikov G, Holman L, Novik L, et al.
NPJ Vaccines
. 2024 Mar;
9(1):67.
PMID: 38553525
Ebola virus disease (EVD) is a filoviral infection caused by virus species of the Ebolavirus genus including Zaire ebolavirus (EBOV) and Sudan ebolavirus (SUDV). We investigated the safety and immunogenicity...
2.
Blazevic A, Edwards R, Xia M, Eickhoff C, Hamzabegovic F, Meza K, et al.
J Infect Dis
. 2023 Nov;
229(5):1498-1508.
PMID: 38019956
Background: A controlled human infection model for assessing tuberculosis (TB) immunity can accelerate new vaccine development. Methods: In this phase 1 dose escalation trial, 92 healthy adults received a single...
3.
Lai L, Rouphael N, Xu Y, Kabbani S, Beck A, Sherman A, et al.
Vaccine
. 2022 Oct;
40(49):7065-7072.
PMID: 36273986
Background: Unadjuvanted A/H7N9 vaccines are poorly immunogenic. The immune response is improved with the addition of MF59, an oil-in-water adjuvant. However, the cellular immunologic responses of MF59-adjuvanted A/H7N9 vaccine are...
4.
Wu R, Idris A, Berkowitz N, Happe M, Gaudinski M, Buettner C, et al.
N Engl J Med
. 2022 Aug;
387(5):397-407.
PMID: 35921449
Background: New approaches for the prevention and elimination of malaria, a leading cause of illness and death among infants and young children globally, are needed. Methods: We conducted a phase...
5.
Rouphael N, Beck A, Kirby A, Liu P, Natrajan M, Lai L, et al.
J Infect Dis
. 2022 Feb;
226(10):1771-1780.
PMID: 35137154
Background: Genogroup II noroviruses are the most common cause of acute infectious gastroenteritis. We evaluated the use of a new GII.2 inoculum in a human challenge. Methods: Forty-four healthy adults...
6.
Lai L, Ault K, Rouphael N, Beck A, Domjahn B, Xu Y, et al.
Vaccines (Basel)
. 2020 Jul;
8(3).
PMID: 32629943
Human papillomavirus virus (HPV) vaccines aim to provide durable protection and are ideal to study the association of cellular with humoral responses. We assessed the duration and characteristics of immune...
7.
Chen G, Coates E, Plummer S, Carter C, Berkowitz N, Conan-Cibotti M, et al.
JAMA
. 2020 Apr;
323(14):1369-1377.
PMID: 32286643
Importance: Chikungunya virus (CHIKV) is a mosquito-borne Alphavirus prevalent worldwide. There are currently no licensed vaccines or therapies. Objective: To evaluate the safety and tolerability of an investigational CHIKV virus-like...
8.
Rouphael N, Hurwitz S, Hart M, Beck A, Anderson E, Deye G, et al.
Antimicrob Agents Chemother
. 2019 Jul;
63(9).
PMID: 31285228
Filociclovir (MBX-400, cyclopropavir) is an antiviral agent with activity against cytomegalovirus (CMV). A phase 1, double-blind, randomized, placebo-controlled (3:1 ratio), single-center, multiple-ascending-dose trial was conducted to assess the safety, tolerability,...
9.
Aluzaite K, Tewhaiti-Smith J, Fraser M, Johnson S, Glen E, Beck A, et al.
R Soc Open Sci
. 2018 Sep;
5(8):172167.
PMID: 30224989
Hepatitis C virus (HCV) and B virus (HBV) infections are highly prevalent, with a high percentage of undiagnosed cases. Knowledge of HCV and its modes of transmission are essential for...
10.
Lai L, Rouphael N, Xu Y, Natrajan M, Beck A, Hart M, et al.
Clin Infect Dis
. 2017 Oct;
66(1):1-10.
PMID: 29020226
Background: There is an urgent need for studies of viral persistence and immunity during human Zika infections to inform planning and conduct of vaccine clinical trials. Methods: In 5 returned...